|
|
|
Insider
Information: |
Boger Joshua S |
Relationship: |
Director, 10% Owner |
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
500,905 |
|
Indirect Shares
|
918,262 |
|
|
Direct
Value |
$131,612,455 |
|
|
Indirect Value
|
$36,181,966 |
|
|
Total
Shares |
1,419,167 |
|
|
Total
Value |
$167,794,420 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Vertex Pharmaceuticals Inc |
VRTX |
Director |
2017-06-08 |
284,088 |
2017-06-08 |
77,811 |
Premium* |
|
Cervomed Ord Shs |
CRVO |
Director, 10% Owner |
2024-02-26 |
216,817 |
2024-02-26 |
840,451 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
762 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 15 of 31
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
VRTX |
Vertex Pharmaceuticals In... |
Director |
|
2012-04-04 |
4 |
OE |
$15.87 |
$63,480 |
D/D |
4,000 |
634,949 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
Director |
|
2012-04-11 |
4 |
AS |
$37.23 |
$148,920 |
D/D |
(4,000) |
630,949 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
Director |
|
2012-04-11 |
4 |
OE |
$15.87 |
$63,480 |
D/D |
4,000 |
634,949 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
Director |
|
2012-04-18 |
4 |
AS |
$35.88 |
$143,520 |
D/D |
(4,000) |
630,949 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
Director |
|
2012-04-18 |
4 |
OE |
$15.87 |
$63,480 |
D/D |
4,000 |
634,949 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
Director |
|
2012-04-25 |
4 |
AS |
$37.72 |
$150,880 |
D/D |
(4,000) |
632,895 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
Director |
|
2012-04-25 |
4 |
OE |
$15.87 |
$63,480 |
D/D |
4,000 |
636,895 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
Director |
|
2012-05-02 |
4 |
AS |
$38.39 |
$153,560 |
D/D |
(4,000) |
632,895 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
Director |
|
2012-05-02 |
4 |
OE |
$15.87 |
$63,480 |
D/D |
4,000 |
636,895 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
Director |
|
2012-05-09 |
4 |
OE |
$15.87 |
$52,593 |
D/D |
3,314 |
636,209 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
Director |
|
2012-05-09 |
4 |
AS |
$60.59 |
$201,228 |
D/D |
(3,314) |
632,895 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
Director |
|
2012-05-16 |
4 |
OE |
$15.60 |
$62,400 |
D/D |
4,000 |
636,895 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
Director |
|
2012-05-16 |
4 |
AS |
$62.88 |
$252,943 |
D/D |
(4,000) |
632,895 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
Director |
|
2012-05-23 |
4 |
OE |
$15.60 |
$62,400 |
D/D |
4,000 |
636,895 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
Director |
|
2012-05-23 |
4 |
AS |
$62.68 |
$251,302 |
D/D |
(4,000) |
632,895 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
Director |
|
2012-06-06 |
4 |
OE |
$15.60 |
$62,400 |
D/D |
4,000 |
636,895 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
Director |
|
2012-06-06 |
4 |
AS |
$58.22 |
$233,071 |
D/D |
(4,000) |
632,895 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
Director |
|
2012-06-13 |
4 |
AS |
$55.65 |
$224,474 |
D/D |
(4,000) |
632,895 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
Director |
|
2012-06-13 |
4 |
OE |
$15.60 |
$62,400 |
D/D |
4,000 |
636,895 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
Director |
|
2012-06-20 |
4 |
AS |
$57.88 |
$232,345 |
D/D |
(4,000) |
632,895 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
Director |
|
2012-06-20 |
4 |
OE |
$15.60 |
$62,400 |
D/D |
4,000 |
636,895 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
Director |
|
2012-06-27 |
4 |
OE |
$15.60 |
$62,400 |
D/D |
4,000 |
636,895 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
Director |
|
2012-06-27 |
4 |
AS |
$60.03 |
$242,826 |
D/D |
(4,000) |
632,895 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
Director |
|
2012-07-05 |
4 |
AS |
$55.55 |
$222,200 |
D/D |
(4,000) |
632,895 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
Director |
|
2012-07-05 |
4 |
OE |
$15.60 |
$62,400 |
D/D |
4,000 |
636,895 |
0 |
- |
|
762 Records found
|
|
Page 15 of 31 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|